Unison Advisors LLC Pfizer Inc Transaction History

Unison Advisors LLC

$1.01 Billion
Q1 2024

A detailed history of Unison Advisors LLC transactions in Pfizer Inc stock. As of the latest transaction made, Unison Advisors LLC holds 85,034 shares of PFE stock, worth $2.36 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

85,034

Previous 83,304 2.08%

Holding current value

$2.36 Million

Previous $2.4 Million 1.63%

% of portfolio

0.23%

Previous 0.25%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	BUY	$25.89 - $29.73 $44,789 - $51,432	1,730 Added 2.08%	85,034 $2.36 Million
Q4 2023 Jan 19, 2024	BUY	$26.13 - $33.94 $26,574 - $34,516	1,017 Added 1.24%	83,304 $2.4 Million
Q3 2023 Oct 05, 2023	BUY	$32.09 - $37.51 $29,169 - $34,096	909 Added 1.12%	82,287 $2.73 Million
Q2 2023 Jul 28, 2023	BUY	$36.12 - $41.79 $28,462 - $32,930	788 Added 0.98%	81,378 $2.98 Million
Q1 2023 Apr 14, 2023	BUY	$39.39 - $51.28 $30,802 - $40,100	782 Added 0.98%	80,590 $3.29 Million

Q4 2022 Jan 23, 2023	BUY	$41.75 - $54.5 $31,604 - $41,256	757 Added 0.96%	79,808 $0
Q3 2022 Oct 13, 2022	BUY	$43.76 - $53.42 $25,774 - $31,464	589 Added 0.75%	79,051 $3.46 Million
Q2 2022 Jul 13, 2022	BUY	$46.53 - $55.17 $28,057 - $33,267	603 Added 0.77%	78,462 $4.11 Million
Q1 2022 Apr 13, 2022	BUY	$45.75 - $56.69 $23,332 - $28,911	510 Added 0.66%	77,859 $4.03 Million
Q4 2021 Jan 27, 2022	BUY	$41.32 - $61.25 $36,072 - $53,471	873 Added 1.14%	77,349 $4.57 Million
Q3 2021 Oct 20, 2021	SELL	$39.25 - $50.42 $738,017 - $948,047	-18,803 Reduced 19.73%	76,476 $3.29 Million
Q2 2021 Jul 28, 2021	BUY	$35.91 - $40.68 $3.42 Million - $3.88 Million	95,279 New	95,279 $3.73 Million

Others Institutions Holding PFE

# of Institutions

3,164

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $156B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Unison Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Unison Advisors LLC with notifications on news.

Account

Unison Advisors LLC Pfizer Inc Transaction History